Effects of alpha7 nicotine acetylcholine receptor on acylation stimulating protein expression and associated mechanism in 3T3-L1 adipocytes

Jing Wu,Zhouyang Jiao,Xinling Du,Qiang Luo,Yufeng Liu,Jindou An
DOI: https://doi.org/10.3760/cma.j.issn.1001-9030.2015.08.033
2015-01-01
Abstract:Objective To investigate the effects of alpha7 nicotine acetylcholine receptor (α7nAChR) on chylomicron (CM)-induced acylation stimulating protein (ASP) expression and its related mechanisms.Methods 3T3-L1 preadipocytes were cultured and induced to differentiate.The expression of complement C3 (C3) and ASP was assessed by enzyme-linked immunosorbent assay (ELISA).The total p38 mitogen-activated protein kinases (p38) and phosphorylated p38 (p-p38) were determined by Western blotting.C5a like receptor 2 (C5L2) mRNA was detected by real-time quantitative polymerase chain reaction (Real-time PCR).Results α7nAChR agonist nicotine (1.0 × 10-9,1.0 × 10-8,1.0 × 10-7 mol/L) pretreatment inhibited CM (200 μg TG/ml,24 h)-induced C3 and ASP release in 3T3-L1 adipocytes (P <0.05),an effect attenuated by α7nAChR selective nicotinic antagonist α-Bungarotoxin (α-BTX) [ASP (pmol/mg cell protein):0.81 ± 0.35 vs.0.71 ± 0.22,P < 0.05;C3 (pmoL/mg cell protein):16.37 ±1.64 vs.12.75 ±0.88,P<0.05].Furthermore,the inhibition of C3 expression by α7nAChR appears to be mediated by a reduction in phosphorylation of p38 (1.65 ±0.11 vs.2.18 ±0.23,P <0.05).In addition,αTnAChR inhibits CM-induced C5L2 mRNA downregulation (0.56 ± 0.08 vs.0.44 ± 0.14,P < 0.05).Conclusion α7nAChR inhibits CM-induced ASP upregulation through downregulating C3 and restoring C5L2 mRNA.p38 signaling transduction pathway may be involved in the regulation of C3 expression.
What problem does this paper attempt to address?